On August 7, 2023, Gossamer Bio, Inc. closed the transaction. The transaction included participation from 70 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -3.00% | -7.78% | -21.10% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
32.89 USD | -0.42% | -1.35% | 2.64B | ||
0.72 USD | -3.00% | -7.78% | 163M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.10% | 163M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+44.47% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- GOSS Stock
- News Gossamer Bio, Inc.
- Gossamer Bio, Inc. announced that it has received $211.849524 million in funding from a group of investors